RxDoctor Payments Data

Dominick Condo, MD

Internal Medicine · Bayonne, NJNPI 1114019692

Payments from drug & device makers

$165in general payments, 2019–2025

Across 11 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$35
  • Novo Nordisk$28
  • Medtronic$27
  • E.r. Squibb & Sons, L.L.C.$26
  • Boston Scientific$20
  • Sunovion Pharmaceuticals Inc.$18
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$165100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$165 in reported general payments places this provider in the 35th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$372,374
Medicare patients
501
Services billed
5,413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban122$96,900
FarxigaDapagliflozin Propanediol87$74,406
OzempicSemaglutide55$54,714
Inderal LaPropranolol Hcl17$52,552
JanuviaSitagliptin Phosphate56$52,076
JubliaEfinaconazole12$39,758
JardianceEmpagliflozin13$24,027
VascepaIcosapent Ethyl28$17,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$15,482
Lagevrio (Eua)Molnupiravir25$13,523
Atorvastatin Calcium949$10,194
Icosapent Ethyl30$10,147
Rosuvastatin Calcium474$7,954
XareltoRivaroxaban13$6,348
Penciclovir11$5,877

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Lagevrio (Eua)$12$65,59981 claims
Novo NordiskOzempic$28$54,71455 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 4,032 internal medicine providers in New Jersey.

Other internal medicine in Bayonne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →